Top

Published in:

01-09-2018 | Clinical Study

Clinical outcomes of perioptic tumors treated with hypofractionated stereotactic radiotherapy using CyberKnife® stereotactic radiosurgery

Authors: Putipun Puataweepong, Mantana Dhanachai, Ake Hansasuta, Somjai Dangprasert, Chomporn Sitathanee, Rawee Ruangkanchanasetr, Pornpan Yongvithisatid

Published in: Journal of Neuro-Oncology | Issue 3/2018

Abstract

Introduction

Stereotactic radiation technique is widely reported as an effective treatment for various types of benign intracranial tumors. However, single fraction radiosurgery (SRS) is not recommended for tumors located close to the optic apparatus due to the restricted radiation tolerance dose of the optic pathway. Recent advances in radiotherapy include advanced frameless radiosurgery using hypofractionated stereotactic radiotherapy (HSRT), and this has become an attractive treatment option for perioptic tumors within 2–3 mm of the optic pathway. Accordingly, the aim of this study was to investigate the clinical outcomes of perioptic tumors treated with HSRT using CyberKnife® (CK) robotic radiosurgery system relative to tumor control, vision preservation and toxicity.

Methods

This retrospective analysis of prospectively collected data included consecutive 100 patients that were diagnosed with and treated for perioptic tumor at the Radiosurgery center, Ramathibodi Hospital during the January 2009 to December 2012 study period.

Results

The median tumor volume was 6.81 cm³ (range 0.37–51.6), and the median prescribed dose was 25 Gy (range 20–35) in 5 fractions (range 3–5). After the median follow-up time of 37.5 months (range 21–103), two patients developed tumor progression at 6 and 34 months post-HSRT. The 5-year overall survival was 97%, and the 5-year local control was 97.5%. At the last follow-up, no vision deterioration or newly developed hypopituitarism was detected in our study.

Conclusions

Although a longer follow-up is needed, HSRT yields a high level of local control and vision preservation, and should be considered a treatment of choice for perioptic tumor located close to the optic apparatus.

Eisenhauer EA, Therasse P, Bogarerts J et al (2008) New response evaluation criteria in solid tumors: revised RECIST guideline. Eur J Cancer 45:228–247CrossRef

Kalapurakal JA (2005) Radiation therapy in the management of pediatric craniopharyngiomas: a review. Childs Nerv Syst 21(8–9):808–816CrossRefPubMed

Flickinger JC, Kondziolka D, Maitz AH, Lunsford LD (2003) Gamma knife radiosurgery of imaging-diagnosed intracranial meningioma. Int J Radiat Oncol Biol Phys 56(3):801–806CrossRefPubMed

Stafford SL, Pollock BE, Foote RL et al (2001) Meningioma radiosurgery: tumor control, outcomes, and complications among 190 consecutive patients. Neurosurgery 49(5):1029–1037 (discussion 37–8)PubMed

Girkin CA, Comey CH, Lunsford LD, Goodman ML, Kline LB (1997) Radiation optic neuropathy after stereotactic radiosurgery. Ophthalmology 104(10):1634–1643CrossRefPubMed

Tishler RB, Loeffler JS, Lunsford LD et al (1993) Tolerance of cranial nerves of the cavernous sinus to radiosurgery. Int J Radiat Oncol Biol Phys 27(2):215–221CrossRefPubMed

Fokas E, Henzel M, Surber G, Hamm K, Engenhart-Cabillic R (2014) Stereotactic radiation therapy for benign meningioma: long-term outcome in 318 patients. Int J Radiat Oncol Biol Phys 89(3):569–575CrossRefPubMed

Solda F, Wharram B, De Ieso PB et al (2013) Long-term efficacy of fractionated radiotherapy for benign meningiomas. Radiother Oncol 109(2):330–334CrossRefPubMed

Stiebel-Kalish H, Reich E, Gal L et al (2012) Visual outcome in meningiomas around anterior visual pathways treated with linear accelerator fractionated stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 82(2):779–788CrossRefPubMed

10.

Barber SM, Teh BS, Baskin DS (2016) Fractionated stereotactic radiotherapy for pituitary adenomas: single-center experience in 75 consecutive patients. Neurosurgery 79(3):406–417CrossRefPubMed

11.

Kim JO, Ma R, Akagami R et al (2013) Long-term outcomes of fractionated stereotactic radiation therapy for pituitary adenomas at the BC Cancer Agency. Int J Radiat Oncol Biol Phys 87(3):528–533CrossRefPubMed

12.

Harrabi SB, Adeberg S, Welzel T et al (2014) Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects. Radiat Oncol 9:203CrossRefPubMedPubMedCentral

13.

Conti A, Pontoriero A, Midili F et al (2015) CyberKnife multisession stereotactic radiosurgery and hypofractionated stereotactic radiotherapy for perioptic meningiomas: intermediate-term results and radiobiological considerations. Springerplus 4:37CrossRefPubMedPubMedCentral

14.

Adler JR Jr, Gibbs IC, Puataweepong P, Chang SD (2006) Visual field preservation after multisession cyberknife radiosurgery for perioptic lesions. Neurosurgery 59(2):244–254 (discussion 254)CrossRefPubMed

15.

Metellus P, Regis J, Muracciole X et al (2005) Evaluation of fractionated radiotherapy and gamma knife radiosurgery in cavernous sinus meningiomas: treatment strategy. Neurosurgery 57(5):873–886CrossRefPubMed

16.

Adler JR Jr, Gibbs IC, Puataweepong P, Chang SD (2008) Visual field preservation after multisession cyberknife radiosurgery for perioptic lesions. Neurosurgery 62(Suppl 2):733–743PubMed

17.

Kim JW, Im YS, Nam DH et al (2008) Preliminary report of multisession gamma knife radiosurgery for benign perioptic lesions: visual outcome in 22 patients. J Korean Neurosurg Soc 44(2):67–71CrossRefPubMedPubMedCentral

18.

Killory BD, Kresl JJ, Wait SD et al (2009) Hypofractionated CyberKnife radiosurgery for perichiasmatic pituitary adenomas: early results. Neurosurgery 64(2 Suppl):A19–A25CrossRefPubMed

19.

Jee TK, Seol HJ, Im YS, Kong DS et al (2014) Fractionated gamma knife radiosurgery for benign perioptic tumors: outcomes of 38 patients in a single institute. Brain Tumor Res Treat 2(2):56–61CrossRefPubMedPubMedCentral

20.

Liao HI, Wang CC, Wei KC et al (2014) Fractionated stereotactic radiosurgery using the Novalis system for the management of pituitary adenomas close to the optic apparatus. J Clin Neurosci 21(1):111–115CrossRefPubMed

21.

Puataweepong P, Dhanachai M, Hansasuta A et al (2016) The clinical outcome of hypofractionated stereotactic radiotherapy with CyberKnife robotic radiosurgery for perioptic pituitary adenoma. Technol Cancer Res Treat 15(6):Np10–NP15CrossRefPubMed

22.

Lee EJ, Cho YH, Yoon K et al (2017) Radiosurgical decompression for benign perioptic tumors causing compressive cranial neuropathies: a feasible alternative to microsurgery? J Neurooncol 131(1):73–81CrossRefPubMed

23.

Minniti G, Amichetti M, Enrici RM (2009) Radiotherapy and radiosurgery for benign skull base meningiomas. Radiat Oncol 4:42CrossRefPubMedPubMedCentral

24.

Leavitt JA, Stafford SL, Link MJ et al (2013) Long term evaluation of radiation-induced optic neuropathy after single-fraction stereoatctic radiosurgery. Int J Radiat Oncol Biol Phys 87:524–527CrossRefPubMed

25.

Pollock BE, Link MJ, Leavitt JA et al (2014) Dose-volume analysis of radiation-induced optic neuropathy after single-fraction stereotactic radiosurgery. Neurosurgery 75:456–460CrossRefPubMed

26.

Mayo C, Martel MK, Marks LB et al (2010) Radiation dose-volume effects of optic nerves and chiasm. Int J Radiat Oncol Biol Phys 76(3 Suppl):S28–S35CrossRefPubMed

27.

Romanelli P, Wowra B, Muacevic A (2007) Multisession CyberKnife radiosurgery for optic nerve sheath meningiomas. Neurosurg Focus 23(6):E11CrossRefPubMed

28.

Colombo F, Casentini L, Cavedon C et al (2009) Cyberknife radiosurgery for benign meningiomas: short-term results in 199 patients. Neurosurgery 64(2 Suppl):A7–A13CrossRefPubMed

29.

Marchetti M, Bianchi S, Milanesi I et al (2011) Multisession radiosurgery for optic nerve sheath meningiomas: an effective option: preliminary results of a single-center experience. Neurosurgery 69(5):1116–1122 (discussion 22–3)PubMed

30.

Milano MT, Grimm J, Soltys SG et al (2018) Single- and multi-fraction stereotactic radiosurgery dose tolerances of the optic pathways. Int J Radiat Oncol Biol Phys. https://doi.org/10.1016/j.ijrobp.2018.01.053 CrossRefPubMed

31.

Tanaka S, Link MJ, Brown PD et al (2010) Gamma knife radiosurgery for patients with prolactin-secreting pituitary adenomas. World Neurosurg 74(1):147–152CrossRefPubMed

32.

Grant RA, Whicker M, Lleva R et al (2014) Efficacy and safety of higher dose stereotactic radiosurgery for functional pituitary adenomas: a preliminary report. World Neurosurg 82(1–2):195–201CrossRefPubMed

33.

Lee CC, Vance ML, Xu Z et al (2014) Stereotactic radiosurgery for acromegaly. J Clin Endocrinol Metab 99(4):1273–1281CrossRefPubMed

34.

Weber DC, Momjian S, Pralong FP et al (2011) Adjuvant or radical fractionated stereotactic radiotherapy for patients with pituitary functional and nonfunctional macroadenoma. Radiat Oncol 6:169CrossRefPubMedPubMedCentral

35.

Yan JL, Chang CN, Chuang CC et al (2013) Long-term follow-up of patients with surgical intractable acromegaly after linear accelerator radiosurgery. J Formos Med Assoc 112(7):416–420CrossRefPubMed

36.

Wilson PJ, De-Loyde KJ, Williams JR, Smee RI (2013) Acromegaly: a single centre’s experience of stereotactic radiosurgery and radiotherapy for growth hormone secreting pituitary tumours with the linear accelerator. J Clin Neurosci 20(11):1506–1513CrossRefPubMed

37.

Castinetti F, Brue T (2009) Radiotherapy and radiosurgery of pituitary adenomas. Presse Med 38(1):133–139CrossRefPubMed

38.

Puataweepong P, Dhanachai M, Dangprasert S et al (2009) Comparison of conventional external radiotherapy and stereotactic radiotherapy in the treatment of pituitary adenoma. J Med Assoc Thai 92(3):382–389PubMed

Title: Clinical outcomes of perioptic tumors treated with hypofractionated stereotactic radiotherapy using CyberKnife® stereotactic radiosurgery
Authors: Putipun Puataweepong
Mantana Dhanachai
Ake Hansasuta
Somjai Dangprasert
Chomporn Sitathanee
Rawee Ruangkanchanasetr
Pornpan Yongvithisatid
Publication date: 01-09-2018
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 3/2018
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-018-2913-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Clinical outcomes of perioptic tumors treated with hypofractionated stereotactic radiotherapy using CyberKnife® stereotactic radiosurgery

Abstract

Introduction

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2018

G6PD as a predictive marker for glioma risk, prognosis and chemosensitivity

Fluorescein sodium-guided biopsy or resection in primary central nervous system lymphomas with contrast-enhancing lesion in MRI

Retrospective study of nivolumab for patients with recurrent high grade gliomas

Outcomes of an electronic social network intervention with neuro-oncology patient family caregivers

Widespread disseminated osseous metastases of intracranial meningioma with over 27-year-survivorship: a unique, idiosyncratic case

The clinical importance of medulloblastoma extent of resection: a systematic review